SEQUENT SCIENTIFIC
Back to Income Statement
|
SEQUENT SCIENTIFIC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹22 Cr | ₹-36 Cr | ₹-121 Cr | ₹41 Cr | ₹95 Cr |
What is the latest Consolidated Net Profit of SEQUENT SCIENTIFIC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹-36 Cr |
| Mar2023 | ₹-121 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹95 Cr |
How is Consolidated Net Profit of SEQUENT SCIENTIFIC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | Positive | |
| Mar2024 | ₹-36 Cr | Negative | |
| Mar2023 | ₹-121 Cr | Negative | |
| Mar2022 | ₹41 Cr | -57.09 | |
| Mar2021 | ₹95 Cr | - | |
Compare Consolidated Net Profit of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹4,912.4 Cr | -3% | -8.3% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | -3% |
-8.3% |
6.8% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses